| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 流感疫苗(元) | 2,385,552.10 | 1,199,248,045.37 | 58,827,704.89 | 1,072,997,826.90 | 11,207,481.69 |
| 狂犬疫苗(元) | 39,721,053.44 | - | - | - | 21,333,922.35 |
| 其他(元) | - | 3,257,775.17 | 1,134,069.38 | 54,814,496.95 | - |
| 营业成本(元) | |||||
| 流感疫苗(元) | -1,574,524.11 | 263,153,079.53 | 13,718,389.27 | 194,802,851.54 | 283,236.58 |
| 狂犬疫苗(元) | 22,134,014.07 | - | - | - | 5,191,182.03 |
| 其他(元) | - | 3,788,234.53 | 1,118,816.43 | 17,755,936.59 | - |
| 毛利(元) | |||||
| 流感疫苗(元) | 3,960,076.21 | 936,094,965.84 | 45,109,315.62 | 878,194,975.36 | 10,924,245.11 |
| 狂犬疫苗(元) | 17,587,039.37 | - | - | - | 16,142,740.32 |
| 其他(元) | - | -530,459.36 | 15,252.95 | 37,058,560.36 | - |
| 毛利率(%) | |||||
| 流感疫苗(%) | 166.00 | 78.06 | 76.68 | 81.84 | 97.47 |
| 狂犬疫苗(%) | 44.28 | - | - | - | 75.67 |
| 其他(%) | - | -16.28 | 1.34 | 67.61 | - |
| 收入构成(%) | |||||
| 流感疫苗(%) | 5.67 | 99.73 | 98.11 | 95.14 | 34.44 |
| 狂犬疫苗(%) | 94.33 | - | - | - | 65.56 |
| 其他(%) | - | 0.27 | 1.89 | 4.86 | - |
| 毛利构成(%) | |||||
| 流感疫苗(%) | 18.38 | 100.06 | 99.97 | 95.95 | 40.36 |
| 狂犬疫苗(%) | 81.62 | - | - | - | 59.64 |
| 其他(%) | - | -0.06 | 0.03 | 4.05 | - |